Intuitive Surgical background and stock listing, the robotics pioneer on Nasdaq

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 07:18.

Intuitive Surgical (US46120E6023) is widely known among investors for its focus on robotic-assisted surgery and its listing on the Nasdaq exchange in the United States. The company has grown into one of the most recognized names in minimally invasive surgery since its founding in the 1990s, with its stock often treated as a benchmark for the medical robotics segment.

Robotic surgery pioneer

Intuitive Surgical focuses on developing and marketing robotic platforms that assist surgeons during minimally invasive procedures in hospitals worldwide. Its core expertise lies in combining mechanical robotic arms, sophisticated imaging, and advanced software to help surgeons perform complex operations through small incisions, which can reduce patient recovery times compared with traditional open surgery.

The company operates from Sunnyvale, California, and over the years has expanded its reach to hospitals in North America, Europe, and Asia through a mix of direct sales and distributor agreements. As its installed base has grown, recurring revenue from instruments, accessories, and system servicing has become an important part of its business model, alongside the initial sale of surgical systems.

Position on Nasdaq and peer context

Intuitive Surgical shares trade on Nasdaq in the United States, giving the stock visibility among international investors who follow major medical technology names. The listing places the company alongside large-cap peers in medtech and life sciences, where investors often compare it with other equipment manufacturers and device developers when assessing capital allocation and sector exposure.

Because the stock is traded on a major U.S. technology and growth-oriented venue, it is commonly included in thematic baskets focused on healthcare innovation, medical devices, and robotics. Institutional and retail investors alike watch its valuation metrics, such as market capitalization, price-to-earnings ratios, and revenue growth, to gauge sentiment toward surgical robotics and related technologies.

How Intuitive Surgical earns revenue

Intuitive Surgical generates revenue primarily through the sale of surgical systems that hospitals install in operating rooms, complemented by recurring sales of single-use instruments and accessories needed for each procedure. Additional recurring revenue comes from service contracts and training services that support hospital staff in using and maintaining the systems.

As more systems are placed globally, procedure volume grows and drives demand for instruments and accessories, which often carry higher margins than initial system sales. This combination of capital equipment and consumables gives Intuitive Surgical a business model that blends up-front investment decisions by hospitals with ongoing usage-based income tied to surgical activity.

Where the stock trades today

Intuitive Surgical shares trade on Nasdaq in the United States. A precise current share price, market capitalization, and intraday trading data are not included here because up-to-date figures require live market data at the moment of reading; investors typically obtain those details from their broker or a current quote service.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.